Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)

Phase: PHASE2 | Sponsor: University Hospital, Basel, Switzerland | Compound: LSD

Status

recruiting

Institution

University Hospital, Basel, Switzerland

Start date

2024-06-09

End date

2028-05-01

Registry ID

NCT05883540

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.